BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33898511)

  • 1. MiR-490-3p Silences CDK1 and Inhibits the Proliferation of Colon Cancer Through an LLPS-Dependent miRISC System.
    Qin D; Wei R; Zhu S; Min L; Zhang S
    Front Mol Biosci; 2021; 8():561678. PubMed ID: 33898511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA TONSL-AS1 regulates miR-490-3p/CDK1 to affect ovarian epithelial carcinoma cell proliferation.
    Liu Y; Li L; Wang X; Wang P; Wang Z
    J Ovarian Res; 2020 May; 13(1):60. PubMed ID: 32414422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diosbulbin B induced G
    Yang R; Wei M; Yang F; Sheng Y; Ji L
    Toxicol Appl Pharmacol; 2018 Oct; 357():1-9. PubMed ID: 30145177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis.
    Jin J; Xu H; Li W; Xu X; Liu H; Wei F
    Front Bioeng Biotechnol; 2020; 8():54. PubMed ID: 32133348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.
    Zheng Y; Zheng Y; Lei W; Xiang L; Chen M
    Mol Cell Probes; 2019 Dec; 48():101445. PubMed ID: 31513891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.
    Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
    Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. USP6NL mediated by LINC00689/miR-142-3p promotes the development of triple-negative breast cancer.
    Ma T; Liu H; Liu Y; Liu T; Wang H; Qiao F; Song L; Zhang L
    BMC Cancer; 2020 Oct; 20(1):998. PubMed ID: 33054738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TUG1 promotes cell proliferation and suppresses apoptosis in osteosarcoma by regulating miR-212-3p/FOXA1 axis.
    Xie C; Chen B; Wu B; Guo J; Cao Y
    Biomed Pharmacother; 2018 Jan; 97():1645-1653. PubMed ID: 29793327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-193a-3p inhibits cell proliferation in prostate cancer by targeting cyclin D1.
    Liu Y; Xu X; Xu X; Li S; Liang Z; Hu Z; Wu J; Zhu Y; Jin X; Wang X; Lin Y; Chen H; Mao Y; Luo J; Zheng X; Xie L
    Oncol Lett; 2017 Nov; 14(5):5121-5128. PubMed ID: 29142597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4.
    Yu Y; Zhao JD; Yang H
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5621-5627. PubMed ID: 31298314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-377-3p inhibits cell metastasis and epithelial-mesenchymal transition in cervical carcinoma through targeting SGK3.
    Zhang XY; Dong XM; Wang FP
    Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4687-4696. PubMed ID: 32432732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.
    Jin J; Liu H; Jin M; Li W; Xu H; Wei F
    Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
    Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
    Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting liquid-liquid phase separation in pancreatic cancer.
    Ming Y; Chen X; Xu Y; Wu Y; Wang C; Zhang T; Mao R; Fan Y
    Transl Cancer Res; 2019 Feb; 8(1):96-103. PubMed ID: 35116738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Non Coding RNA SNHG16 Supports Colon Cancer Cell Growth by Modulating miR-302a-3p/AKT Axis.
    Ke D; Wang Q; Ke S; Zou L; Wang Q
    Pathol Oncol Res; 2020 Jul; 26(3):1605-1613. PubMed ID: 31502038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-144-3p inhibits cell proliferation and promotes apoptosis in castration-resistant prostate cancer by targeting CEP55.
    You B; Zhang KC
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7660-7670. PubMed ID: 30536308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Novel Long Noncoding RNA TUSC7 Inhibits Proliferation by Sponging MiR-211 in Colorectal Cancer.
    Xu J; Zhang R; Zhao J
    Cell Physiol Biochem; 2017; 41(2):635-644. PubMed ID: 28214867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the aberrant A1CF-FAM224A-miR-590-3p-ZNF143 positive feedback loop attenuated malignant biological behaviors of glioma cells.
    Song Y; Shao L; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Shen S; Chen J; Li Z; Liu Y
    J Exp Clin Cancer Res; 2019 Jun; 38(1):248. PubMed ID: 31186064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.